Related Experiment Video
Updated: Aug 6, 2026

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
Published on: April 26, 2024
Gut Microbiome in Depression with and without REM Sleep Behavior Disorder
Yuhua Yang1,2, Ningning Li1,2, Li Zhou1,2,3
1Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong SAR, China.
Abstract:
Major depressive disorder (MDD) is a risk factor for neurodegeneration, yet its heterogeneity makes identifying at-risk subtype challenging. Notably, MDD frequently co-occurs with REM sleep behavior disorder (RBD), a specific prodrome of α-synucleinopathy. It remains unclear whether comorbid MDD + RBD reflects a benign antidepressant effect, or higher neurodegenerative risk. Given growing recognition of gut-brain axis in neuropsychiatry, we aimed to delineate microbial signatures of MDD + RBD. We employed a four-group case-control design (N = 420) comprising 124 healthy controls (HC); 80 MDD without RBD features (MDD-only); 82 MDD + RBD; and 134 iRBD without psychiatric disease. All participants underwent clinical evaluation and provided fecal samples for metagenomic sequencing. Random Forest model was used to distinguish MDD + RBD, and further assessed in a validation dataset of 65 participants with MDD + RBD (n = 31) and MDD-only (n = 34). MDD + RBD exhibited prodromal neurodegenerative features, including elevated total likelihood ratio of prodromal Parkinson's Disease, olfactory deficits, and subtle motor signs. The microbial composition in MDD + RBD differed from HC and MDD-only, while resembling iRBD. Taxonomically, MDD + RBD exhibited an iRBD-like dysbiosis (e.g., enriched Akkermansia muciniphila, Ruthenibacterium lactatiformans; depleted Faecalibacterium prausnitzii), alongside depression-associated shifts (e.g., Streptococcus parasanguinis and Actinomyces oris). Functionally, MDD + RBD showed attenuated capacity of B‑vitamin biosynthesis and polysaccharides degradation, mirroring iRBD. The Random Forest machine-learning model distinguished MDD + RBD in older adults from MDD-only with an AUC of 0.73 in cross-validation and 0.79 in the validation dataset. MDD + RBD may represent a biologically distinct depression subtype associated with potential neurodegenerative risk. Gut microbiome provides a candidate approach for potential risk stratification in psychiatric populations.
Insights
Major depressive disorder with REM sleep behavior disorder (MDD+RBD) may be a distinct subtype indicating neurodegeneration risk. Gut microbiome analysis revealed unique microbial signatures in MDD+RBD, differentiating it from other groups.
Area of Science:
- Neuropsychiatry
- Microbiome Research
- Neurodegenerative Diseases
Background:
- Major depressive disorder (MDD) is a risk factor for neurodegeneration, but its heterogeneity complicates subtype identification.
- REM sleep behavior disorder (RBD) is a prodrome of α-synucleinopathy, and its comorbidity with MDD warrants investigation into neurodegenerative risk.
- The gut-brain axis plays a crucial role in neuropsychiatric disorders, suggesting microbial signatures may differentiate MDD subtypes.
Purpose of the Study:
- To delineate the microbial signatures associated with comorbid Major Depressive Disorder and REM Sleep Behavior Disorder (MDD+RBD).
- To investigate whether MDD+RBD represents a distinct subtype with higher neurodegenerative risk compared to MDD alone.
- To explore the potential of the gut microbiome for risk stratification in psychiatric populations.
Main Methods:
- A four-group case-control study (N=420) including healthy controls (HC), MDD-only, MDD+RBD, and idiopathic RBD (iRBD).
- Clinical evaluations and fecal metagenomic sequencing were performed on all participants.
- A Random Forest machine-learning model was developed to distinguish MDD+RBD from MDD-only, validated on an independent dataset.
Main Results:
- MDD+RBD patients exhibited prodromal neurodegenerative features, including olfactory deficits and subtle motor signs, resembling iRBD.
- Microbial composition in MDD+RBD differed significantly from HC and MDD-only, showing an iRBD-like dysbiosis (e.g., enriched Akkermansia muciniphila, depleted Faecalibacterium prausnitzii).
- The Random Forest model accurately distinguished MDD+RBD from MDD-only with an AUC of 0.79 in the validation dataset, indicating distinct microbial profiles.
Conclusions:
- MDD+RBD may represent a biologically distinct subtype of depression associated with increased neurodegenerative risk.
- Gut microbiome alterations in MDD+RBD patients mirror those in iRBD, suggesting shared pathophysiological pathways.
- Microbiome analysis offers a promising avenue for identifying individuals at higher risk for neurodegeneration within psychiatric cohorts.
Related Concept Videos
Gut-Brain Axis
REM Sleep Behavior Disorder
RBD is significantly associated with...
Depression: Overview
Dysbiosis of the Gut Microbiota
Microbiota Modulation by Antibiotics
G-protein Coupled Receptors